122 related articles for article (PubMed ID: 7532909)
1. Biologic characterization of hereditary non-polyposis colorectal cancer. Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters.
Losi L; Fante R; Di Gregorio C; Aisoni ML; Lanza G; Maestri I; Roncucci L; Pedroni M; Ponz de Leon M
Am J Clin Pathol; 1995 Mar; 103(3):265-70. PubMed ID: 7532909
[TBL] [Abstract][Full Text] [Related]
2. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.
Young J; Simms LA; Biden KG; Wynter C; Whitehall V; Karamatic R; George J; Goldblatt J; Walpole I; Robin SA; Borten MM; Stitz R; Searle J; McKeone D; Fraser L; Purdie DR; Podger K; Price R; Buttenshaw R; Walsh MD; Barker M; Leggett BA; Jass JR
Am J Pathol; 2001 Dec; 159(6):2107-16. PubMed ID: 11733361
[TBL] [Abstract][Full Text] [Related]
3. HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differences.
Jass JR
Fam Cancer; 2004; 3(2):93-100. PubMed ID: 15340259
[TBL] [Abstract][Full Text] [Related]
4. More differences between HNPCC-related and sporadic carcinomas from the endometrium as compared to the colon.
van den Bos M; van den Hoven M; Jongejan E; van der Leij F; Michels M; Schakenraad S; Aben K; Hoogerbrugge N; Ligtenberg M; van Krieken JH
Am J Surg Pathol; 2004 Jun; 28(6):706-11. PubMed ID: 15166662
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer.
McGivern A; Wynter CV; Whitehall VL; Kambara T; Spring KJ; Walsh MD; Barker MA; Arnold S; Simms LA; Leggett BA; Young J; Jass JR
Fam Cancer; 2004; 3(2):101-7. PubMed ID: 15340260
[TBL] [Abstract][Full Text] [Related]
6. Survival of patients with Stage III colon cancer is improved in hereditary non-polyposis colorectal cancer compared with sporadic cases. A Danish registry based study.
Brixen LM; Bernstein IT; Bülow S; Ehrnrooth E
Colorectal Dis; 2013 Jul; 15(7):816-23. PubMed ID: 23350633
[TBL] [Abstract][Full Text] [Related]
7. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
[TBL] [Abstract][Full Text] [Related]
8. Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: An analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry.
Oliveira Ferreira F; Napoli Ferreira CC; Rossi BM; Toshihiko Nakagawa W; Aguilar S; Monteiro Santos EM; Vierira Costa ML; Lopes A
Fam Cancer; 2004; 3(1):41-7. PubMed ID: 15131405
[TBL] [Abstract][Full Text] [Related]
9. K-ras and p53 mutations in hereditary non-polyposis colorectal cancers.
Losi L; Ponz de Leon M; Jiricny J; Di Gregorio C; Benatti P; Percesepe A; Fante R; Roncucci L; Pedroni M; Benhattar J
Int J Cancer; 1997 Feb; 74(1):94-6. PubMed ID: 9036876
[TBL] [Abstract][Full Text] [Related]
10. Preoperative serum levels of the carcinoembryonic antigen in hereditary non-polyposis colorectal cancer compared to levels in sporadic colorectal cancer.
Schiemann U; Günther S; Gross M; Henke G; Müller-Koch Y; König A; Muders M; Folwaczny C; Mussack T; Holinski-Feder E
Cancer Detect Prev; 2005; 29(4):356-60. PubMed ID: 16122885
[TBL] [Abstract][Full Text] [Related]
11. Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer.
Bertario L; Russo A; Sala P; Eboli M; Radice P; Presciuttini S; Andreola S; Rodriguez-Bigas MA; Pizzetti P; Spinelli P
Int J Cancer; 1999 Jan; 80(2):183-7. PubMed ID: 9935197
[TBL] [Abstract][Full Text] [Related]
12. Comparison of survival between patients with hereditary non polyposis colorectal cancer (HNPCC) and sporadic colorectal cancer.
Haghighi MM; Vahedi M; Mohebbi SR; Pourhoseingholi MA; Fatemi SR; Zali MR
Asian Pac J Cancer Prev; 2009; 10(2):209-12. PubMed ID: 19537885
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of DNA ploidy pattern and nucleolar organizer regions (AgNOR) in colorectal carcinoma.
Eminović-Behrem S; Trobonjaca Z; Petrovecki M; Dobi-Babić R; Dujmović M; Jonjić N
Croat Med J; 2000 Jun; 41(2):154-8. PubMed ID: 10853043
[TBL] [Abstract][Full Text] [Related]
14. Nuclear DNA content and nucleolar organizer regions in colorectal cancer.
Adachi Y; Kido A; Mori M; Matsushima T; Shimono R; Inoue T; Sugimachi K
J Surg Oncol; 1995 Jul; 59(3):177-80. PubMed ID: 7609524
[TBL] [Abstract][Full Text] [Related]
15. Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene.
Lage PA; Albuquerque C; Sousa RG; Cravo ML; Salazar M; Francisco I; Maia L; Claro I; Suspiro A; Rodrigues P; Raposo H; Fidalgo PA; Nobre-Leitão C
Cancer; 2004 Jul; 101(1):172-7. PubMed ID: 15222003
[TBL] [Abstract][Full Text] [Related]
16. Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer.
Lindgren G; Liljegren A; Jaramillo E; Rubio C; Lindblom A
Gut; 2002 Feb; 50(2):228-34. PubMed ID: 11788565
[TBL] [Abstract][Full Text] [Related]
17. Tumoral expression of nuclear cofactor FHL2 is associated with lymphatic metastasis in sporadic but not in HNPCC-associated colorectal cancer.
Al-Nomani L; Friedrichs J; Schüle R; Büttner R; Friedrichs N
Pathol Res Pract; 2015 Feb; 211(2):171-4. PubMed ID: 25554651
[TBL] [Abstract][Full Text] [Related]
18. Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma.
Fante R; Roncucci L; Di GregorioC ; Tamassia MG; Losi L; Benatti P; Pedroni M; Percesepe A; De Pietri S; Ponz de Leon M
Cancer; 1996 May; 77(10):2013-21. PubMed ID: 8640664
[TBL] [Abstract][Full Text] [Related]
19. Stromal expression of invasion-promoting, matrix-degrading proteases MMP-1 and -9 and the Ets 1 transcription factor in HNPCC carcinomas and sporadic colorectal cancers.
Behrens P; Mathiak M; Mangold E; Kirdorf S; Wellmann A; Fogt F; Rothe M; Florin A; Wernert N
Int J Cancer; 2003 Nov; 107(2):183-8. PubMed ID: 12949792
[TBL] [Abstract][Full Text] [Related]
20. Diploid predominance in hereditary nonpolyposis colorectal carcinoma evaluated by flow cytometry.
Kouri M; Laasonen A; Mecklin JP; Järvinen H; Franssila K; Pyrhönen S
Cancer; 1990 Apr; 65(8):1825-9. PubMed ID: 2317760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
